Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture

MLA

de, Vries F., et al. “Use of Inhaled and Oral Glucocorticoids, Severity of Inflammatory Disease and Risk of Hip/Femur Fracture.” Journal of Internal Medicine, vol. 261, no. 2, Feb. 2007, pp. 170–77. EBSCOhost, https://doi.org/10.1111/j.1365-2796.2006.01754.x.

APA

de, V. F., Pouwels, S., Lammers, J., Leufkens, H., Bracke, M., Cooper, C., van, S. T., de Vries, F., Lammers, J. W. J., Leufkens, H. G. M., & van Staa, T. P. (2007). Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture. Journal of Internal Medicine, 261(2), 170–177. https://doi.org/10.1111/j.1365-2796.2006.01754.x

Chicago

de, Vries F, S Pouwels, Jwj Lammers, Hgm Leufkens, M Bracke, C Cooper, Staa TP van, et al. 2007. “Use of Inhaled and Oral Glucocorticoids, Severity of Inflammatory Disease and Risk of Hip/Femur Fracture.” Journal of Internal Medicine 261 (2): 170–77. doi:10.1111/j.1365-2796.2006.01754.x.